Nuvation Bio Inc.
Nuvation Bio Inc. (NUVB) Revenue
Annual & quarterly revenue history · segment & region breakdown
NUVB · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsNuvation Bio Inc. trailing twelve-month (TTM) revenue is $0.14B, an increase of 698.96% year-over-year from $0.06B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.06B | +$0.06B | +698.96% |
| 2024-12-31 | $0.01B | +$0.01B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare NUVB revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Nuvation Bio Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Nuvation Bio Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Nuvation Bio Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NUVB revenue · 5 questionsNUVB's trailing twelve-month (TTM) revenue is $0.14B. That is an increase of 698.96% year-over-year from $0.06B in FY2025.
▸ Source: FMP · Nuvation Bio Inc. SEC filings · GAAP · Nuvation Bio Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026